https://xpertspv.com/ 2026-04-03T19:13:02Z daily 1.0 https://xpertspv.com/forum 2026-04-03T19:13:02Z hourly 0.9 https://xpertspv.com/login 2026-04-03T19:13:02Z monthly 0.5 https://xpertspv.com/register 2026-04-03T19:13:02Z monthly 0.5 https://xpertspv.com/profile 2026-04-03T19:13:02Z weekly 0.7 https://xpertspv.com/about-us 2026-04-03T19:13:02Z monthly 0.6 https://xpertspv.com/reset-password 2026-04-03T19:13:02Z monthly 0.3 https://xpertspv.com/users 2026-04-03T19:13:02Z weekly 0.8 https://xpertspv.com/terms-of-service 2026-04-03T19:13:02Z monthly 0.3 https://xpertspv.com/privacy-policy 2026-04-03T19:13:02Z monthly 0.3 https://xpertspv.com/questions/38/what-is-the-most-overlooked-risk-in-routine-literature-screening 2026-03-29T11:48:54Z weekly 0.8 https://xpertspv.com/questions/37/should-literature-screening-remain-largely-manual 2026-03-29T11:48:52Z weekly 0.8 https://xpertspv.com/questions/36/special-situation-and-overdose-in-clinical-trial-protocol 2026-03-04T04:55:12Z weekly 0.8 https://xpertspv.com/questions/34/this-is-a-demo-title 2025-10-26T10:02:32Z weekly 0.8 https://xpertspv.com/questions/33/minimum-frequency-for-literature-searches 2025-10-11T09:21:57Z weekly 0.8 https://xpertspv.com/questions/32/criteria-for-stopping-identified-risk-presentation-in-pbrer 2025-10-11T09:21:56Z weekly 0.8 https://xpertspv.com/questions/31/impact-of-disease-indication-cases-on-dpa-scores 2025-10-11T09:21:54Z weekly 0.8 https://xpertspv.com/questions/30/guidance-for-compliance-checks-in-pv-agreements 2025-10-11T09:21:53Z weekly 0.8 https://xpertspv.com/questions/29/data-correction-day-zero-date-determination 2025-10-11T09:21:52Z weekly 0.8 https://xpertspv.com/questions/28/medical-review-efficiency-line-listings-vs-safety-database 2025-10-11T09:21:50Z weekly 0.8 https://xpertspv.com/questions/27/factors-for-upgrading-safety-topic-classification 2025-10-11T09:21:49Z weekly 0.8 https://xpertspv.com/questions/26/7-day-timeline-for-life-threatening-susar-with-comparator-product 2025-10-11T09:21:47Z weekly 0.8 https://xpertspv.com/questions/25/monitoring-safety-data-from-social-media 2025-10-11T09:21:46Z weekly 0.8 https://xpertspv.com/questions/24/listedness-assessment-for-special-adverse-events 2025-10-11T09:21:45Z weekly 0.8 https://xpertspv.com/questions/23/listedness-assessment-for-upper-respiratory-tract-infection 2025-10-11T09:21:44Z weekly 0.8 https://xpertspv.com/questions/22/general-criteria-for-creating-tfuqs-to-an-adverse-event 2025-10-11T09:21:42Z weekly 0.8 https://xpertspv.com/questions/21/regulatory-timelines-for-icsr-submission-of-susar-category 2025-10-11T09:21:41Z weekly 0.8 https://xpertspv.com/questions/20/demo-questions-for-the-update 2025-08-24T11:12:32Z weekly 0.8 https://xpertspv.com/questions/15/udr-abbreviation-in-signal-detection-databases 2025-04-26T09:40:00Z weekly 0.8 https://xpertspv.com/questions/14/any-suggestions-for-llt-or-pt-selection-in-meddra-coding 2025-04-16T13:14:02Z weekly 0.8 https://xpertspv.com/questions/13/how-to-identify-duplicate-case-reports-from-multiple-sources 2025-04-16T13:12:40Z weekly 0.8 https://xpertspv.com/questions/12/what-steps-would-you-generally-take-for-validating-this-signal 2025-04-16T13:10:09Z weekly 0.8 https://xpertspv.com/questions/11/anyone-here-have-idea-on-performing-data-mining-in-faers-for-marketed-generic-medicinal-products 2025-04-16T13:08:49Z weekly 0.8 https://xpertspv.com/questions/10/would-we-agree-and-proceed-to-change-our-company-s-corde-data-sheet 2025-04-16T13:06:35Z weekly 0.8 https://xpertspv.com/questions/9/what-are-the-general-key-performance-indicators-in-risk-management-activities-in-your-company 2025-04-16T13:03:30Z weekly 0.8 https://xpertspv.com/questions/8/is-there-any-company-who-follows-digital-technology-for-dhpcl-circulation 2025-04-16T13:02:03Z weekly 0.8 https://xpertspv.com/questions/7/how-frequently-do-you-check-pv-training-compliance-in-your-company-for-the-outsourced-resources-activities-to-a-vendor 2025-04-16T12:58:10Z weekly 0.8 https://xpertspv.com/questions/6/do-we-need-to-consider-this-topic-as-signal-for-comprehensive-assessment-or-can-we-provide-only-the-cumulative-analysis-while-preparing-pbrer-for-next-reporting-interval 2025-04-16T12:54:57Z weekly 0.8 https://xpertspv.com/questions/5/can-this-become-an-expedited-sae-report 2025-04-16T12:48:01Z weekly 0.8 https://xpertspv.com/questions/4/do-we-need-to-file-a-deviation-if-a-single-susar-icsr-is-submitted-to-usfda-beyond-15-day-timeline 2025-04-16T12:45:34Z weekly 0.8 https://xpertspv.com/questions/3/can-anyone-provide-guidance-on-processing-a-ct-case-received-from-other-company-for-which-there-is-no-agreement-in-place 2025-04-16T12:42:36Z weekly 0.8 https://xpertspv.com/questions/2/if-a-literature-article-contains-information-about-active-substance-without-any-information-on-brand-name-then-how-can-we-determine-whether-the-product-mentioned-in-article-is-a-company-drug 2025-04-16T12:40:12Z weekly 0.8 https://xpertspv.com/questions/1/when-should-we-consider-day-0-for-literature-cases 2025-04-16T12:38:20Z weekly 0.8